Philip Morris International recently held an online media communication meeting and announced the latest development of the heat-not-burn e-cigarette product “IQOS”. Philip Morris said that after passing PMTA (Tobacco Market Access License) certification, IQOS has again obtained the FDA’s MRTP (Scientific Risk Assessment Modified Tobacco Products) certification.
According to the regulations of the U.S. Food and Drug Administration (ie: FDA), both traditional tobacco and new tobacco products need to pass PMTA certification before they can be legally sold in the U.S. market. As the first new heat-not-burn product to pass PMTA, IQOS has gained a good reputation in many countries around the world.
After passing the MRTP certification this time, IQOS further proved the harm reduction effect of its new tobacco products compared to traditional tobacco. From a market perspective, as one of the world’s top tobacco groups, Philip Morris International’s promotion of IQOS may have a certain impact on its cigarette product line. A move of long-term significance”, so IQOS will be the main tobacco product of the group to market in the future.
Philip Morris International CEO Tan Chongbo said at the communication meeting that IQOS is now listed in more than 50 countries around the world, and about 10.6 million smokers have completely replaced traditional cigarettes by using IQOS. “The recognition of MRTP has proven the ability of IQOS to reduce harm from a scientific point of view. Next, as a company, one of the most important changes we expect is that the government will be able to introduce more complete supervision methods in the future and implement compliance Fiscal measures for changes in product form.”